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eight women, ages 16 to 42 years (mean 32 years)-with clinically definite MS were studied by using high-resolution agarose gel electrophoresis combined with immunofixation as previously described in detail (7) . Monospecific antisera to heavy and light chains of immunoglobulins were from Dakopatts, Copenhagen, Denmark, and Behringwerke, Marburg,
F.R.G. Before electrophoresis, all urine samples
were concentrated up to 600-fold in collodionbags (Sartorius Membranlilter, G#{246}ttingen, F.R.G.) by extraction under reduced pressure (8). The same procedure was adopted to concentrate the CSF samples 80-to 100-fold.
Results and DIscussIon
No homogeneous immunoglobulin band was found in the serum samples from any of the 10 patients. The CSF oligoclonal pattern, consisting of three to nine discrete bands, was recognized in eight patients. The two patients without detectable CSF oligoclonal banding had had MS for more than five years, had received priorsteroid therapy,and had no clinical evidence of disease activity in the preceding 12 months. Homogeneous (single or multiple) bands reacting exclusively with one of the two light-chain-type antisera were observed in urines from three patients with newly diagnosed MS, who were in a phase of active disease and had not received prior therapy. The monoclonal free light chains were of K type in two patients, and one patient had simultaneously bands of i'cand X type exhibiting different electrophoretic mobiities (Figure 1) . The oligoclonal IgG bands in the CSF sample from this latter patient displayed light chains of K as well as X type, in contrast to all the other CSF samples, which contained IgG bands of K type. The urinary excretion of monoclonal free light chains [calculated from the combined data on total protein content and the densitometric evaluation of the monoclonal bands (8)] ranged from 0.02 to 0.07 g/L.
Up to now we have used the described procedure (7) to investigate more than 1000 urine samples for the presence myelomatosis (8-10) . About 200 of these urine samples, which were obtained from individuals without serum monoclonal immunoglobulins, had low total protein contents and were investigated in exactly the same way as urines from MS patients, including concentration up to 600-fold. We never found homogeneous bands reacting exclusively with either K or X light chain antisera in patients without an immunoproliferative disorder of the B-cell lineage. Conversely, polyclonal free light chains, which can be clearly distinguished from Bence Jones protein because of their heterogeneous electrophoretic mobility on agarose gel resulting in a diffuse background stain between the application point and the a2-zone (11), were almost invariably present in urine concentrated nearly 400-fold from normal subjects.
With particular reference to neurological patients, we have recently examined five patients with cerebral infarction or transient ischemic attacks, four patients with polyneuropathy, and three patients with amyotrophic lateral sclerosis. No homogeneous light chain band was observed in the urine from any of these 12 patients.
Bands consisting of free light chains in addition to oligoclonal IgG bands containing K or X light chains have been reported in CSF samples from MS patients and have been interpreted as a byproduct of antibody-producing cells being intensely stimulated 5, 12) . Interestingly, the free lightchain bands were mostly of A type, in contrast to the K lightchain-type predominance of the oligoclonal IgO bands. The frequency of their detection appears to vary with the technique used, but evidence suggests that they constitute a large percentage of CSF immunoglobulin (12) .
The Bence Jones proteinuria in MS patients represents most probably an "overflow" proteinuria, the urinary excretion of monoclonal free light chains resulting from the excess production that escapes tubular reabsorption and catabolism. If so, the production of restricted immunoglobulin populations in MS may not be limited exclusively to the CSF compartment, unless a "sink" effect occurs due to an alteration in the function ofthe blood-CSF barrier. Because the kidney seems to have a considerable capacity for catabolism of light chains (13) , and MS patients are generally young adults without significant impairment of renal function, the occurrence of easily detectable amounts of Bence Jones proteinuria would appear to reflect an important overproduction of monoclonal free light chains, at least in certain phases of the disease.
Further study is required to assess whether the occurrence of Bence Jones proteinuria is clinically important in the evaluation and management of patients with MS. Our findings suggest that the investigation of the urinary protein pattern by means ofa procedure that is sensitive, easily performed and interpreted, economical, and rapid (7) may usefully be carried out in conjunction with analyses of CSF and serum proteins with little more technical effort by the clinical chemistry laboratory.
